Early therapeutic doses of radiation were chosen based on the skin reaction expected. Which outcome was used to estimate those doses?

• A. Skin irritation and erythema
• B. Open ulcers on the skin
• C. Burned appearance of skin
• D. Sloughing of skin

Answer: (A)

The idea being tested is using an observable, dose-dependent skin reaction to gauge how much radiation is being delivered. Early on, clinicians relied on the skin’s response because it’s easy to observe and correlates with the amount of radiation reaching tissues. Erythema, or skin redness, along with irritation, appears at relatively lower, manageable doses and serves as a practical indicator of tissue tolerance. By watching for this early change, clinicians could estimate doses that would be effective against tumor tissue while avoiding excessive damage to skin. More severe outcomes—open ulcers, a burned appearance, or sloughing—indicate much higher levels of injury and aren’t used for initial dose estimation because they reflect late or excessive damage rather than the safe, early tolerance benchmark.